扩大准入药物简介:雷替格拉韦(raltegravir, RAL, MK-0518)。

{"title":"扩大准入药物简介:雷替格拉韦(raltegravir, RAL, MK-0518)。","authors":"Amanda R Colquitt, Paul A Pham","doi":"","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":83056,"journal":{"name":"The Hopkins HIV report : a bimonthly newsletter for healthcare providers","volume":"19 1","pages":"11-2"},"PeriodicalIF":0.0000,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Expanded access drug profile: raltegravir (RAL, MK-0518).\",\"authors\":\"Amanda R Colquitt, Paul A Pham\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":83056,\"journal\":{\"name\":\"The Hopkins HIV report : a bimonthly newsletter for healthcare providers\",\"volume\":\"19 1\",\"pages\":\"11-2\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2007-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Hopkins HIV report : a bimonthly newsletter for healthcare providers\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Hopkins HIV report : a bimonthly newsletter for healthcare providers","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}